openPR Logo
Press release

What's driving the Human Growth Hormones Deficiency (GHD) Drugs Market Size Key Players are: Ascendis Pharma A/S, Novo Nordisk A/S, Versartis Inc., Opko Health Inc., Pfizer Inc

06-04-2019 08:42 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: marketstudyreport.com

/ PR Agency: marketstudyreport
What's driving the Human Growth Hormones Deficiency (GHD) Drugs

Global Human Growth Hormones Deficiency (GHD) Drugs Market Report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges.

The report titled Global Human Growth Hormones Deficiency (GHD) Drugs Market Assessment: Current Market, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023 also analyzes the overall sizing, growth and forecast of Growth Hormone Deficiency Drugs Market for the global market.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/1227770/?utm_source=openpr.com&utm_medium=Deepak

Company Analysis Ascendis Pharma A/S, Novo Nordisk A/S, Versartis Inc., Opko Health Inc., Pfizer Inc.

The report presents the market potential of four major pipeline drugs (TransCon-hGH, Somapacitan, Somavaratan, Somatrogonmeant) for the treatment of human Growth Hormone Deficiency (GHD). These four drugs that fall in the various categories of paediatrics and adults by end user have been recognized as being clinically effective in human Growth Hormone Deficiency treatment. Expected to be launched in the market within the next 4-5 years, these four potential drugs are likely to bring about major changes in the way Growth Hormone Deficiency is treated globally.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global human Growth Hormone Deficiency (GHD) Pipeline Drugs Market by assessing the potential of the four drugs that will be launched in the near future. Also, the report assesses the results of various clinical trials undertaken for each of the four drugs, the product profile, description and regulatory phase of each of the four drugs. Also, 7Ps Analysis (Patent, Phase, Pathway, Patient, Physician, Payer, Partner) has been done for each of the four drugs to present the current perspective.

Over the recent years, the human Growth Hormone Deficiency Drugs market is growing rapidly due to rising prevalence of patients with Growth Hormone Deficiency (GHD) around the world. Globally, the growth of human Growth Hormone Deficiency Drugs market is driven by increased penetration of drugs by market players coupled with introduction of new drugs with improved patient compliance.

The global human Growth Hormone Deficiency (GHD) Pipeline Drugs Market is projected to display a robust growth during 2018 2023, chiefly driven by low efficacy and poor dosing schedules of present drugs and improved safety and efficacy of investigational drugs. The report has covered and analysed the present human Growth Hormone Deficiency (GHD) drugs in the market and has also analysed potential of four major pipeline drugs. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.

Global human Growth Hormone Deficiency (GHD) Pipeline Drugs Assessment TransCon-hGH, Somapacitan, Somavaratan, Somatrogon (Forecast Period: 2020-2023)
Market Potential
Clinical Trials
Product Description
Regulatory Phases
7Ps Analysis
Global human Growth Hormone Deficiency (GHD) Pipeline Drugs Market Sizing and Growth
Actual Period: 2013-2017
Forecast Period: 2018-2023

Regional Analysis - Human Growth Hormone Deficiency (GHD) Pipeline Drugs Market Sizing and Growth: North America, Europe, Rest of the World
Actual Period: 2013-2017
Forecast Period: 2018-2023

Country Analysis - Human Growth Hormone Deficiency (GHD) Pipeline Drugs Market Sizing and Growth: US, UK, France, Spain, Germany, Japan
Actual Period: 2013-2017
Forecast Period: 2018-2023

Other Report Highlights

Customization of the Report

The report could be customized according to the client s specific research requirements. No additional cost will be required to pay for limited additional research.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/1227770/?utm_source=openpr.com&utm_medium=Deepak

Table of Content

1. Research Methodology
2. Executive Summary
3. Growth Hormone Deficiency Drugs Product - An Overview
3.1. Growth Hormone (GH) and its Function
3.2. Growth Hormone Deficiency (GHD) and its Symptoms
3.3. Causes of Growth Hormone Deficiency (GHD)
4. Diagnosis of Growth Hormone Deficiency (GHD)
5. Treatment of Growth Hormone Deficiency (GHD)
6. Global Growth Hormone Drugs Market
6.1. Global Growth Hormone Drugs Market Size, By value, 2013-2017
6.2. Global Growth Hormone Drugs Market Size, By value, 2018-2023
7. Global Growth Hormone Deficiency Drugs Market
7.1. Global Growth Hormone Deficiency Drugs Market Size, By value, 2013-2017
7.2. Global Growth Hormone Deficiency Drugs Market Size, By value, 2018-2023
8. Global Growth Hormone Deficiency Drugs Market, By End User
8.1. Global Growth Hormone Deficiency Drugs Market, By End User: Break down (%)
8.1.1. Global Growth Hormone Deficiency Drugs Market, By End User: 2017%
8.1.2. Global Growth Hormone Deficiency Drugs Market, By End User: 2023%
8.2. Global Growth Hormone Deficiency Drugs Market, By End User By Pediatrics
8.2.1. By Value (2013 2017)
8.2.2. By Value (2018 2023)
8.3. Global Growth Hormone Deficiency Drugs Market, By End User By Adult
8.3.1. By Value (2013 2017)
8.3.2. By Value (2018 2023)
9. Global Growth Hormone Deficiency Drugs Market: Regional Analysis
9.1. North America Growth Hormone Deficiency Drugs Market
9.1.1. By Value (2013 2017)
9.1.2. By Value (2018 2023)
9.2. Europe Growth Hormone Deficiency Drugs Market
9.2.1. By Value (2013 2017)
9.2.2. By Value (2018 2023)
9.3. ROW Growth Hormone Deficiency Drugs Market
9.3.1. By Value (2013 2017)
9.3.2. By Value (2018 2023)
10. Global Growth Hormone Deficiency Drugs Market: Country Analysis
10.1. U.S. Growth Hormone Deficiency Drugs Market
10.1.1. By Value (2013 2017)
10.1.2. By Value (2018 2023)
10.2. U.K. Growth Hormone Deficiency Drugs Market
10.2.1. By Value (2013 2017)
10.2.2. By Value (2018 2023)
10.3. France Growth Hormone Deficiency Drugs Market
10.3.1. By Value (2013 2017)
10.3.2. By Value (2018 2023)
10.4. Germany Growth Hormone Deficiency Drugs Market
10.4.1. By Value (2013 2017)
10.4.2. By Value (2018 2023)
10.5. Spain Growth Hormone Deficiency Drugs Market
10.5.1. By Value (2013 2017)
10.5.2. By Value (2018 2023)
10.6. Japan Growth Hormone Deficiency Drugs Market
10.6.1. By Value (2013 2017)
10.6.2. By Value (2018 2023)
11. human Growth Hormone Deficiency (hGHD) Pipeline Drugs Coverage
11.1. hGHD Pipeline Drugs TransCon-hGH
11.1.1. Description
11.1.2. Regulatory Milestones
11.1.3. Advantages & Disadvantages
11.1.4. Product Profile & Launch Date
11.1.5. Clinical Trials and Status
11.1.6. Pivotal Clinical Trials and Results
11.1.7. TransCon-hGH Global Market Potential
11.1.8. TransCon-hGH Global Market Potential
11.2. hGHD Pipeline Drugs Somapacitan
11.2.1. Description
11.2.2. Regulatory Milestones
11.2.3. Advantages & Disadvantages
11.2.4. Product Profile & Launch Date
11.2.5. Clinical Trials and Status
11.2.6. Pivotal Clinical Trials and Results
11.2.7. Somapacitan Global Market Potential
11.2.8. Somapacitan 7Ps Analysis
11.3. hGHD Pipeline Drugs Somavaratan
11.3.1. Description
11.3.2. Regulatory Milestones
11.3.3. Advantages & Disadvantages
11.3.4. Product Profile & Launch Date
11.3.5. Clinical Trials and Status
11.3.6. Pivotal Clinical Trials and Results
11.3.7. Somavaratan Global Market Potential
11.3.8. Somavaratan 7Ps Analysis
11.4. hGHD Pipeline Drugs Somatrogon/ Lagova
11.4.1. Description
11.4.2. Regulatory Milestones

More Details on this Report: https://www.marketstudyreport.com/reports/global-human-growth-hormone-deficiency-ghd-drugs-market-assessment-current-market-pipeline-review-clinical-trials-market-potential-forecast-to-2023/?utm_source=openpr.com&utm_medium=Deepak

Contact Us:

Market Study Report LLC
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: www.marketstudyreport.com
Blog: www.marketstudyreport.com/blog

About Us:

Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Human Growth Hormones Deficiency (GHD) Drugs Market Size Key Players are: Ascendis Pharma A/S, Novo Nordisk A/S, Versartis Inc., Opko Health Inc., Pfizer Inc here

News-ID: 1764700 • Views:

More Releases from marketstudyreport.com

Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Power Technologies (Schneider Electric), Simplex, Shenzhen Sikes, Pite Tech
Load Bank Market Growth Prospectus by 2028 - Business Opportunities by ASCO Powe …
A concise assortment of data on the 'Load Bank Market' offers an exhaustive study targeting current market trends influencing the business across assorted regions. Significant details related to market size, market share, applications, and statistics are put together to convey an ensemble prediction of the industry. The research further focuses on comprehensive competitor analysis in addition to highlighting growth strategies embraced by market leaders. Load Bank Market Size was estimated
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - John Deere, CNH Industrial, Kubota, AGCO, Claas, Yanmar, Mahindra, LOVOL
Agriculture Equipment Market is Expected to Reach USD 161640 Million by 2028 - J …
Global Agriculture Equipment Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of the market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Agriculture Equipment Market Size was estimated at USD 114110 million in 2021 and is projected to reach USD 161640 million by 2028, exhibiting a CAGR of
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc., Volkswagen AG, SAIC Motors, BYD Auto Co. Ltd., BMW Group, Nissan Motor Co. Ltd., Hyundai Group
Electric Vehicle Market Size to grow at a CAGR of 23.5% through 2028| Tesla Inc. …
Global Electric Vehicle Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. The electric vehicles (EVs) market is estimated to witness a robust growth rate of 23.5% during the period 2019-2028. The operation is done to stop ligament tears and
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - Garrett Motion, Hanon Systems, UQM Technologies, FISCHER Fuel Cell Compressor
Fuel Cell Air Compressor Market is Expected to Reach USD 512.3 Million by 2028 - …
Global Fuel Cell Air Compressor Market with respect to the pivotal drivers influencing the revenue graph of this business sphere. The current trends of market with the geographical landscape, demand, remuneration scale, and growth of this vertical have also been included in this report. Global Fuel Cell Air Compressor Market Size was estimated at USD 215.1 million in 2021 and is projected to reach USD 512.3 million by 2028, exhibiting

All 5 Releases


More Releases for Hormone

Hormone Replacement Therapy Market Report- Segment by Application Menopause, Hyp …
The Hormone Replacement Therapy Market research report presents an intensive and coordinated exploration of the current circumstance, market key elements, Hormone Replacement Therapy Market methodologies, and central participants' development in the business. The investigation helps controllers and corporate leaders in developing cost-effective decisions. Hormone Replacement Therapy Market provides an evenhanded and extensive assessment of existing examples, factors, obstacles, limits, headway, possibilities/quick development areas that will help partners create business plans
Competitive and Opportunities Analysis of Hormone Replacement Therapy Market of …
The global hormone replacement therapy market accounted for US$ 7.16 billion in 2020 and is estimated to be US$ 14.7 billion by 2030 and is anticipated to register a CAGR of 7.50%. Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause.These symptoms can include hot flashes, vaginal atrophy, accelerated skin aging,
Growth Hormone Deficiency (GHD) Treatment Market
Growth Hormone Deficiency (GHD) Treatment Market: Overview The growth hormone deficiency (GHD) treatment market has made some notable strides on the back of the growing role of GH replacement therapy in managing GHD in adults. Advances in understanding clinical syndrome of GHD and understanding of diagnosis are key trends boosting the GHD treatment market. Clinical practices pertaining to pharmacological management of the syndrome in the GHD treatment market have made remarkable
Luteinizing Hormone-releasing Hormone Analogs Drugs Market Analysis by Manufactu …
" Los Angeles, United States – – QY Research offers an overarching research and analysis-based study on the global Luteinizing Hormone-releasing Hormone Analogs Drugs market, covering growth prospects, market development potential, profitability, supply and demand, and other important subjects. The report presented here comes out as a highly reliable source of information and data on the global Luteinizing Hormone-releasing Hormone Analogs Drugs market. The researchers and analysts who have prepared the
Luteinizing Hormone-releasing Hormone Analogs Market Size, Analysis, Research, S …
" Los Angeles, United States – – QY Research offers an overarching research and analysis-based study on the global Luteinizing Hormone-releasing Hormone Analogs market, covering growth prospects, market development potential, profitability, supply and demand, and other important subjects. The report presented here comes out as a highly reliable source of information and data on the global Luteinizing Hormone-releasing Hormone Analogs market. The researchers and analysts who have prepared the report used
Peptide Hormone Market- Key Development by 2026
Worldwide Peptide Hormone Market report of 2019 provides a detailed market overview as well as industry analysis for / of companies, manufacturers and distributors covering data on gross margin, cost structure, consumption value, sale price and more. The recent research report on the global Peptide Hormone market presents the latest industry data and future trends, allowing you to recognize the products and end users driving Revenue growth and profitability of the